MORGANTI, STEFANIA

MORGANTI, STEFANIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 47 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer 2026 Morganti, StefaniaCurigliano, Giuseppe + Article (author) -
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives 2025 Marra, AMorganti, SCurigliano, G + Article (author) -
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021 2024 Curigliano, GiuseppeCriscitiello, CarmenMorganti, StefaniaCorti, ChiaraMiller, Robert + Article (author) -
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer 2024 Morganti S.Curigliano G. + Article (author) -
PARP Inhibitors for Breast Cancer Treatment 2024 Morganti StefaniaMarra AntonioGiugliano FedericaBerton Giachetti Pier Paolo MariaCurigliano GiuseppeCriscitiello Carmen + Article (author) -
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials 2024 Giugliano, FedericaUliano, JacopoMorganti, StefaniaFerraro, EmanuelaTrapani, DarioZagami, PaolaBoldrini, LauraCarnevale Schianca, AmbraCriscitiello, CarmenMarra, AntonioCurigliano, Giuseppe + Article (author) -
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer 2024 Morganti S.Curigliano G. + Article (author) -
I diritti dei morenti in diversi setting di cura al tempo del Covid-19. Uno studio retrospettivo trasversale sulle opinioni degli operatori sanitari. 2023 Borsellino PGallucci MMorganti SPiga AClerici CASalardi S + Article (author) -
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study 2023 Morganti, StefaniaMarra, AntonioAscione, LilianaVenetis, KonstantinosSajjadi, ElhamZagami, PaolaGiugliano, FedericaBerton Giachetti, Pier Paolo MariaCorti, ChiaraDe Camilli, ElisaCurigliano, GiuseppeFusco, NicolaCriscitiello, Carmen + Article (author) -
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 2023 Sartori G.Vianello A.Nobili A.Mannucci P. M.Violi F.Franchi C.Ardoino I.Barbagallo M.Serafini G.Cappellini M. D.Fabio G.Scaramellini N.Di Stefano V.Leoni S.Di Mauro A. D.Maira D.Clerici M.Di Mauro A. D.Fabrizi M.Martelengo M.Lenti M. V.Pisati M.Cattaneo F.Manzoni F.Gallo P.Corsi M.Brucato A.Squintani G. L.Cerruti L.Di Meo I.Schiavone S.Amoruso E.Fracanzani A. L.Tiraboschi S.Cespiati A.Oberti G.Sigon G.Cinque F.Peyvandi F.Agosti P.Pagliaro E.Semproni E.Monzani V.Savojardo V.Pallini G.Kassem S.Castiglioni L.Bertolotti M.Orlandi L.Battaglia R.Maio R.Ruggeri E.Damiani G.Filippini E.Ghio R.Moreo G.Morganti S.Montalto G.Rizzo A.Catalano A.Caruso R.Quadri R.Vannini G.Harari S.Napoli F.Cattaneo M.Fracasso P.Damanti S. + Article (author) -
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials 2022 Venetis K.Morganti S.Sajjadi E.Curci C.Criscitiello C.Fusco N. + Article (author) -
Management of Patients with Cardiac Toxicity: The Point of View of the Oncologist 2022 Paola ZagamiStefania MorgantiGiuseppe Curigliano + Book Part (author) -
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation? 2022 Morganti S.Marra A.Crimini E.Zagami P.Curigliano G. + Article (author) -
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer 2022 Morganti, SMarra, AVenetis, KSajjadi, EAscione, LCorti, CZagami, PZattoni, LCurigliano, GFusco, NCriscitiello, C + Article (author) -
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 2022 Tarantino, PaoloAntonarelli, GabrieleBoscolo Bielo, LucaMarra, AntonioCrimini, EdoardoGiugliano, FedericaZagami, PaolaCorti, ChiaraTrapani, DarioMorganti, StefaniaCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls 2022 Morganti S.Ferraro E.Ascione L.Vivanet G.Curigliano G.Fusco N.Criscitiello C. + Article (author) -
How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed? 2022 Morganti, S.Bianchini, G.Curigliano, G.Criscitiello, C. + Article (author) -
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 2021 Crimini E.Corti C.Repetto M.Giugliano F.Antonarelli G.Zagami P.Morganti S.Uliano J.Curigliano G. + Article (author) -
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards : data from the RePoSI Registry 2021 Nobili A.Mannucci P. M.Licata G.Salerno F.Cesari M.Franchi C.Ardoino I.Pulixi E. A.Barbagallo M.Fabbri E.Cappellini M. D.Maira D.Di Stefano V.Fabio G.Scaramellini N.Damanti S.Clerici M.Lenti M. V.Pisati M.Manzoni F.Gallo P.Annoni G.Brucato A.Amoruso E.Tiraboschi S.Cespiati A.Oberti G.Sigon G.Peyvandi F.Rossio R.Agosti P.Monzani V.Savojardo V.Pallini G.Poletto C.Maio R.Ruggeri E.Damiani G.Mattioli M.Moreo G.Gasparini F.Prolo S.Berra S.Nava M. C.Piccinelli V.Martinelli S.Morganti S.Artoni A.Montalto G.Catalano A.Caruso R.Riva P.Quadri R.Vannini G.Harari S.Napoli F. + Article (author) -
COVID-19 related risk in patients enrolled in early-phase clinical trials 2021 Morganti, SCorti, CVivanet, GCrimini, EAntonarelli, GCurigliano, G + Article (author) -